Results for
"[search-keyword]"
Sponsor content
308 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO LUPIN 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO LUPIN 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet blister pack.
-
Prescription medicine decision summaryTGA decision: Teriparatide Lupin and LAPL and GH (teriparatide acetate) are approved for the treatment of osteoporosis.
-
ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe (364111)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ICATIBANT GH icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe.
-
Cancellation or suspensionRegulatory action due to the product appearing to the Secretary that the quality, safety or efficacy of the goods was unacceptable, effective 29/03/2023
-
Prescription medicine registrationActive ingredients: Teriparatide.